C
Cora N. Sternberg
Researcher at Cornell University
Publications - 747
Citations - 57991
Cora N. Sternberg is an academic researcher from Cornell University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 92, co-authored 663 publications receiving 48986 citations. Previous affiliations of Cora N. Sternberg include CTO Hospital & North Shore University Hospital.
Papers
More filters
Journal ArticleDOI
Phase I/II trial of intravesical methotrexate for superficial bladder tumors
Cora N. Sternberg,Alan Yagoda,Neil H. Bander,Willet F. Whitmore,Jeffry L. Huffman,Martin Fleisher,Myron R. Melamed,Michael P. Fanucchi,Phyllis Hollander,E. Darracott Vaughan +9 more
TL;DR: Despite MTX's established activity in systemic treatment of advanced bladder carcinoma, this study failed to demonstrate any clinical response to intravesically administered MTX, in doses of up to 500 mg/m2, and in concentrations ofup to 4.9×10-2M.
Journal Article
Neo-adjuvant and adjuvant chemotherapy in locally advanced bladder cancer.
Journal ArticleDOI
CARD: Randomized, open-label study of cabazitaxel (CBZ) vs abiraterone (ABI) or enzalutamide (ENZ) in metastatic castration-resistant prostate cancer (mCRPC)
R. de Wit,Gero Kramer,J.-C. Eymard,J.S. de Bono,Cora N. Sternberg,Karim Fizazi,Bertrand Tombal,Christian Wülfing,Aristotle Bamias,Joan Carles,Roberto Iacovelli,Bohuslav Melichar,Asgerdur Sverrisdottir,Christine Theodore,Susan Feyerabend,Carole Helissey,P. Picard,Ayse Ozatilgan,Christine Geffriaud-Ricouard,Daniel Castellano +19 more
TL;DR: CBZ significantly improved clinically important patient outcomes including rPFS and OS vs ART in patients with mCRPC previously treated with DOC and an alternative ART, and should be the preferred option in this setting.
Journal ArticleDOI
Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC).
Nizar M. Tannir,Thomas Powles,Bernard Escudier,Frede Donskov,Viktor Grünwald,Cora N. Sternberg,Manuela Schmidinger,Patrick Schöffski,Cezary Szczylik,Katriina Peltola,Dmitry Nosov,Bohuslav Melichar,Douglas O. Clary,Christian Scheffold,Robert J. Motzer,Toni K. Choueiri +15 more
TL;DR: A retrospective analysis of pts treated with targeted therapy, pts who were older and had mummified appendix found that nephrectomy was more commonly performed in patients with advanced RCC.
Journal ArticleDOI
The evolving role of chemotherapy in advanced urothelial cancer.
Fabio Calabrò,Cora N. Sternberg +1 more
TL;DR: This review focuses on chemotherapy in the management of patients with advanced urothelial cancer, with a look towards the future and the next generation of clinical trials evaluating novel agents, targeted agents and the possibility of customizing chemotherapy on the basis of the chemosensitivity.